Products with Anti-osteoporosis bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN2889 | Baohuoside VII |
| 1. Baohuoside aglycone possesses cardioprotective effect in prevention of ischemia/ reperfusion injury and reduce the myocardial infraction, the mechnism is due to the reduction of the injury of free radicals. 2. Baohuoside VII in vivo exhibits significant anti-osteoporosis activity. | |
| BCN2998 | 8-Prenylnaringenin |
| 8-Prenylnaringenin is a phytoestrogen with high estrogenic activity, it shows more potent effects on promoting osteoblastic bone formation and inhibiting osteoclastic bone resorption by ERα instead of ERβ than the two classic phytoestrogens: genistein and daidzein. 8-Prenylnaringenin at all assayed doses (0.001-20 µM) presumably improves mitochondrial function, whereas a high dose of XN (5 µM) worsens the functionality of this organelle. | |
| BCN3003 | Przewaquinone C |
| 1. Przewaquinone C shows antioxidant properties. | |
| BCN3091 | 2-Hydroxy-1-methoxyanthraquinone |
| 1. 2-Hydroxy-1-methoxy- anthraquinone can promote osteoblast proliferation, and can inhibit osteoclast TRAP activity and bone resorption, suggests that it has antiosteoporotic activity. | |
| BCN3271 | Neoeriocitrin |
| Neoeriocitrin has antioxidant capacity, it could rescue the inhibition effect of cell differentiation induced by PD98059 to some degree.Neoeriocitrin may be a new promising candidate drug for treatment of osteoporosis. | |
